×
News Home

Where Does GSK plc (GSK) Stock Fall in the Drug Manufacturers - General Field After It Has Risen 7.75% This Week?

Tuesday, October 04, 2022 11:03 AM | InvestorsObserver Analysts
Where Does GSK plc (GSK) Stock Fall in the Drug Manufacturers - General Field After It Has Risen 7.75% This Week?

The 40 rating InvestorsObserver gives to GSK plc (GSK) stock puts it near the middle of the Drug Manufacturers - General industry. In addition to scoring higher than 47 percent of stocks in the Drug Manufacturers - General industry, GSK’s 40 overall rating means the stock scores better than 40 percent of all stocks.

Overall Score - 40
GSK has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on GSK!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 40 means the stock is more attractive than 40 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With GSK plc Stock Today?

GSK plc (GSK) stock is trading at $30.88 as of 10:59 AM on Tuesday, Oct 4, a gain of $0.63, or 2.08% from the previous closing price of $30.25. The stock has traded between $30.62 and $31.01 so far today. Volume today is less active than usual. So far 2,510,080 shares have traded compared to average volume of 6,820,744 shares. Click Here to get the full Stock Report for GSK plc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App